Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • Log out
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Cell and Tumor Biology

Identification of Channels Promoting Calcium Spikes and Waves in HT1080 Tumor Cells

Their Apparent Roles in Cell Motility and Invasion

Ji-Biao Huang, Andrei L. Kindzelskii, Andrea J. Clark and Howard R. Petty
Ji-Biao Huang
Departments of 1 Ophthalmology and Visual Sciences and 2Microbiology and Immunology, The University of Michigan Medical School, Ann Arbor, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrei L. Kindzelskii
Departments of 1 Ophthalmology and Visual Sciences and 2Microbiology and Immunology, The University of Michigan Medical School, Ann Arbor, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea J. Clark
Departments of 1 Ophthalmology and Visual Sciences and 2Microbiology and Immunology, The University of Michigan Medical School, Ann Arbor, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Howard R. Petty
Departments of 1 Ophthalmology and Visual Sciences and 2Microbiology and Immunology, The University of Michigan Medical School, Ann Arbor, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/0008-5472.CAN-03-3501 Published April 2004
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Intracellular Ca2+ signals have been associated with cell polarization and locomotion. As cell motility underlies metastasis, we have sought to better characterize the Ca2+ signaling events in HT1080 fibrosarcoma cells. We have tested the hypothesis that low voltage-activated (LVA) and nonvoltage-gated (NVG) channels of HT1080 cells participate in dynamic Ca2+-signaling events leading to cell migration and invasion. Immunofluorescence microscopy has shown that HT1080 cells express LVA T-type Ca2+ channels uniformly about the cell periphery, whereas the transient receptor potential-1 (a NVG cation channel) protein appears as punctate spots about a cell’s periphery. HT1080 cells exhibit periodic intracellular Ca2+ spikes. High-speed imaging revealed that the Ca2+ spikes were composed of a single Ca2+ wave traveling unidirectionally about the periphery of the cytoplasm in a clockwise fashion (as viewed from basal to apical surfaces). The T-type Ca2+ channel blocker mibefradil inhibited Ca2+ spikes and waves on cells and, in parallel, inhibited cell motility and invasion in a dose-dependent manner. Similar changes were noted with the NVG cation channel blockers Gd3+ and carboxyamido-triazole. The combination of LVA and NVG blockers further reduced Matrigel invasiveness. However, the Ca2+ channel blockers nicardipine, SKF96365, diltiazem, and verapamil had no effect at appropriate doses. These results indicate that certain LVA and NVG channels regulate HT1080 cell motility. In addition to providing novel information regarding cancer cell motility, we suggest that it may be possible to design drugs that inhibit a key Ca2+ wave, thereby enhancing the efficacy of emerging therapeutic protocols.

INTRODUCTION

The invasion and metastasis of tumor cells require cell migration (1 , 2) . Cell migration is a cyclic process involving the repetitive extension of invadopodia/lamellipodia at the leading edge, the formation of adhesion sites, contraction of the cell body, and the release of trailing adhesion sites. The cyclic morphological and adherence changes observed during cell migration are accompanied by repetitive Ca2+ signals, which take the form of Ca2+ spikes or oscillations. Ca2+ transients have been observed in migrating neurons, neutrophils, fibroblasts, eosinophils, tumor cells, and other cell types (3, 4, 5, 6, 7, 8, 9, 10) . These oscillations are thought to participate in coordinating the cyclic temporal features of cell migration, such as pseudopod extension, actin assembly, integrin regulation, the phosphorylation-mediated regulation of focal adhesion formation, and pericellular proteolysis (1, 2, 3, 4, 5, 6, 7, 8, 9, 10) . Thus, repetitive Ca2+ signals likely play an important role in the repetitive structural and functional changes required for cell movement.

Intracellular Ca2+ spikes may involve Ca2+ release from intracellular stores as well as Ca2+ entry from the extracellular environment. Ca2+ entry from the extracellular environment is mediated by Ca2+-permeable ion channels of the plasma membrane, of which the voltage-gated Ca2+ channels are best characterized (11) . Five types of high voltage-activated (HVA) Ca2+ channels (named L-, N-, P-, Q-, and R-type) and one type of low voltage-activated (LVA) Ca2+ channel (known as T-type) have been identified based on the pharmacological and biophysical characteristics of their currents. HVA channels are broadly distributed on neurons (12) , myocytes (13) , etc., where they participate in functions such as neuronal excitability and muscle contraction. T-type Ca2+ channels are found on many cell types (14) where they serve to limit the electrical load and transiently activate cells as a “pacemaker” (14 , 15) .

Nonvoltage-gated (NVG) Ca2+ influx channels are activated on binding intracellular and/or extracellular messengers, chemical or mechanical stress, and by the Ca2+ level of intracellular stores (16) . Among these channels, transient receptor potential (TRP) and TRP-like channels are molecularly identified and distributed in a variety of tissues and species (17) . TRPs are likely identical to several NVG channels, such as: (a) store-operated channels (18 , 19) ; (b) mechanosensitive cation channels (20) ; and (c) receptor-activated cation channels (21) . However, the specific physiological functions of TRP and TRP-like channels have not been rigorously established. Nonetheless, carboxyamido-triazole (CAI), an inhibitor of NVG Ca2+ channels, induces tumor cell apoptosis (22) and inhibits tumor cell growth and invasion (23 , 24) , thus implying that NVG Ca2+ channels are closely related with tumor cell physiology.

As previous studies have suggested that: (a) the LVA channel blocker mibefradil inhibits leukocyte adhesion and locomotion (25 , 26) ; (b) the NVG Ca2+ channel blocker CAI inhibits tumor cell invasion (23) ; and (c) unlike muscle cells, which require strong membrane depolarization and high intracellular Ca2+ elevation, cell adhesion and migration require transient cell activation and rapid inactivation, which is usually the function of T-type Ca2+ channels and TRP/TRP-like channels (27 , 28) , we have tested the hypothesis that LVA and NVG Ca2+ channels participate in tumor cell signaling. This study provides direct physical evidence that the Ca2+ signal associated with tumor cell migration is a traveling wave, which requires the participation of both NVG and LVA channels for propagation. Our work not only suggests that mibefradil may enhance the antimetastatic activity of compounds such as CAI, but our studies of signaling waves also provide a new route to understanding basic signaling pathways and a means to search for new drugs.

MATERIALS AND METHODS

Cell Preparation.

HT1080 cells were incubated in DMEM supplied with 10% FCS and 1% antibiotics. Cells were passaged by detachment from culture flasks with a trypsin/EDTA solution (Sigma Chemical Co., St. Louis, MO) in PBS for 5 min at 37°C. For high-speed imaging and emission microfluorometry, cells were prelabeled with indo-1-AM at 5 μg/ml for 20 min at 37°C (29) .

Materials.

Tetramethylrhodamine isothiocyanate, FITC, BAPTA-AM, and indo-1-AM were obtained from Molecular Probes, Inc. (Eugene, OR). Fibronectin, verapamil, mibefradil, GdCl3, and nicardipine were purchased from Sigma. EDTA was obtained from Fischer Scientific (Pittsburgh, PA). CAI was the generous gift of Dr. R. Schultz, Drug Synthesis & Chemistry Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute (Bethesda, MD). A polyclonal rabbit anti-TRP-1 antibody was purchased from Chemicon International, Inc. (Temecula, CA).

Anti-T-type Ca2+ Channel Antibody.

Several previous workers have prepared polyclonal antibodies directed against the T-type Ca2+ channel (30 , 31) . The antibody was prepared as described by using a peptide corresponding to amino acids 1–22 of the NH2-terminal region of human α1G subunit of the low-voltage T-type Ca2+ channel with the addition of a COOH-terminal cysteine: NH2-MDEEEDGAGAEESGQPRSFMRL(C)-COOH (30) . The purified peptide was conjugated to keyhole limpet hemocyanin and then used to immunize rabbits (Bio-Synthesis, Inc., Lewisville, TX). The labeled IgG fraction was found to specifically label cells.

Cell Motility and Phagokinetic Tracks.

Cell motility was assessed by the Albrecht-Buehler method (32) as modified by Scott et al. (33) . Briefly, coverslips were dipped into a 0.17% gelatin solution and then coated with a colloidal gold layer. A suspension of 5000 cells/ml was treated with or without Ca2+ channel blockers and then seeded onto the gold-coated coverslips. After 22 h of incubation, the samples were fixed with 3.7% glutaraldehyde. The tracks produced by the cells were viewed by brightfield microscopy with a ×10 objective. Thirty randomly selected tracks were measured for each slide.

Cell Invasion.

In vitro tumor cell invasion was assessed using a Biocoat Matrigel invasion chamber (BD Biosciences, Bedford, MA) with cell culture inserts containing an 8-μm pore size membrane with a thin Matrigel basement membrane matrix as described previously (34) . One-half milliliter of cells (5 × 104 cells/ml) in serum-free DMEM with or without Ca2+ channel blockers was added to the cell culture insert of a Biocoat Matrigel invasion chamber. Fibronectin (25 μg/ml) was added in the outer chamber as a chemoattractant. The cells were then incubated at 37°C in humidified 5% CO2 conditions for 22 h. To quantitate tumor cell invasion, noninvading cells were removed from the top surface of the membrane by scrubbing gently with a cotton-tipped swab. The cells on the bottom surface of the membrane were fixed with Diff-Quik stain set (Dade Behring, Newark, DE) and counted to determine the number of cells that passed through the Matrigel and membrane layers.

Microfluorometry.

Quantitative microfluorometry was performed on single cells using a Peltier-cooled photomultiplier tube D104 system (Photon Technology, Lawrenceville, NJ) attached to a Zeiss Axiovert 35 (Carl Zeiss, New York, NY) fluorescence microscope (29) . A monochromator and fiber-optically coupled xenon lamp were controlled by FeliX software (Photon Technology). For indo-1-labeling experiments, the excitation was set to 350 nm (10-nm bandpass). Emission was detected using a 390LP dichroic reflector and 405DF43 emission filter. The photomultiplier tube output was plotted as a function of time.

Fluorescence Microscopy.

Fluorescence microscopy was performed with an Axiovert 135 fluorescence microscope with a high numerical aperture condenser, quartz objective, and an AttoArc mercury lamp (Zeiss). For immunfluorescence microscopy, cells were fixed with 3.7% glutaraldehyde for 20 min at room temperature. Samples were washed and then labeled with the first and second step antibodies. To minimize nonspecific binding, 1% BSA was included in these solutions. Images from multiple focal planes were collected using a z-scan apparatus (Veytek, Inc., Fairfield, IA) and cooled Retiga 1300 camera (Q-Imaging, British Columbia, Canada) or an intensified charge-coupled device camera (Hamamatsu, Hamamatsu City, Japan). Images were managed, processed, and deconvoluted using Supermicro Ultra 320 workstation with the software packages: Image-Pro, Microtome, Image-Scan, and Vox-Blast (Veytek). A narrow bandpass filter set with excitation at 485DF20 and emission at 530DF30 nm and a long-pass dichroic mirror at 510 nm were used. Representative sections of immunostained fluorescent samples were collected.

High-Speed Fluorescence Microscopy.

High-speed microscopy was performed using an Axiovert 135 fluorescence microscope with a quartz condenser, quartz objective, and an AttoArc mercury lamp (Zeiss). To detect fluorescence changes in the short wavelength emission region of indo-1, a 355HT15 exciter, 390LP dichroic reflector, and 405DF43 emission filter were used. To increase light collection efficiency, the microscope’s bottom port was used. This port was fiberoptically coupled to the input of an Acton-150 (Acton Instruments, Acton, MA) imaging spectrophotometer. The exit side was connected to a liquid N2-cooled intensifier attached to a Peltier-cooled I-MAX-512 camera (∼−20°C; Princeton Instruments, Trenton, NJ; Refs. 34, 35, 36 ). A Gen-II tube was used to provide maximal efficiency in the violet-blue region of the spectrum (29) , where indo-1 emits. The camera was controlled by a high-speed Princeton ST-133 interface and Stanford Research Systems (Sunnyvale, CA) DG-535 delay gate generator (37) . A custom-built computer with dual 3.06 GHz Xenon processors with 1 MB onboard cache each, 3-Gb RAM, 3.2 Tb of hard drive space with 64 MB cache, and a RAID-5 hard drive management system was used. For experiments, 2 Gb of RAM was allocated as a RAM disk. Winspec-32 (version 2.5.14.1; Princeton Instruments) software was used with a PCI communication accelerator. To improve computer acquisition times, the size of the pixel detection array of the charge-coupled device (CCD) chip was adjusted using a Virtual-Chip plug-in. Winspec CPU calls were given system priority to enhance the instrument’s duty cycle. Data were acquired without reporting to the monitor to further improve system speed. Data capture used a software-allocated RAM disk.

RESULTS

Immunofluorescent Staining of T-Type Ca2+ Channels and TRP1 Cation Channels on HT1080 Cells.

In the present study, we test the hypothesis that LVA (T-type) and NVG channels participate in the signaling mechanism(s) necessary for HT1080 cell migration. Therefore, we sought to confirm that structural elements of these channels are expressed by HT1080 cells using immunofluorescence microscopy. HT1080 cells were stained with a rabbit anti-T-type Ca2+ channel antibody followed by a FITC-conjugated antirabbit IgG antibody. Stacks of fluorescence micrographs were obtained from individual cells followed by deconvolution analyses of the z-scans. Fig. 1, A and B ⇓ show differential interference contrast microscopy and fluorescence micrographs of an HT1080 cell. The T-type channel is located primarily about the cell’s circumference. Fig. 1, C and D ⇓ show a similar experiment using a rabbit anti-TRP1 antibody/FITC-conjugated antirabbit IgG staining. Although TRP1 staining was largely found at the cell periphery, the labeling was punctate in appearance. Labeling was often absent from pseudopods and may include a granule fraction near the plasma membrane. In addition, the z-scan/deconvolution image of Fig. 1D ⇓ suggests that minor labeling of the endoplasmic reticulum is also observed with the anti-TRP1 reagent. This is consistent with the fact that the fixation protocol results in permeabilization of the cell. Although previous studies have shown that tumor cells express T-type channel message, these studies now identify the structural expression of TRP1 and T-type channels by HT1080 cells.

Fig. 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.

Immunofluorescence staining of T-type Ca2+ channels and transient receptor potential 1 cation channels of HT1080 cells. Adherent HT1080 cells were fixed with glutaraldehyde and then labeled with rabbit anti-T-type Ca2+ channel polyclonal antibody (2 μg/ml; A and B) or rabbit antitransient receptor potential 1 cation channel polyclonal antibody (2 μg/ml; C and D), respectively, followed by labeling with a tetramethylrhodamine isothiocyanate-conjugated goat antirabbit antibody (1 μg/ml). Representative differential interference contrast microscopy (A and C) and deconvoluted z-scan fluorescence (B and D) images are shown. Although the T-type channels are largely distributed randomly at the cell periphery, the transient receptor potential 1 channels are found to have a more punctate distribution about the periphery (n = 3; ×980).

HT1080 Cells Exhibit Ca2+ Oscillations that Are Blocked by Mibefradil and Gd3+.

We next evaluated Ca2+ signal oscillations in HT1080 cells. Cells were labeled with indo-1-AM as described in “Materials and Methods.” HT1080 cells were suspended in HBSS and then incubated at 37°C for 20 min to allow the labeled cells to adhere to glass coverslips. Microfluorometry of untreated polarized cells showed a sustained series of Ca2+ spikes at 20-s intervals (Fig. 2 ⇓ , trace 1). To observe the longitudinal properties of these Ca2+ spikes, a long-time base was used in Fig. 2 ⇓ . However, to observe the temporal details of each Ca2+ spike, data were also acquired using a short-time base. Fig. 3 ⇓ , trace 1 shows a Ca2+ spike of an untreated HT1080 cell. This shows a typical Ca2+ spike profile consisting of a low-intensity shoulder on the leading edge, brief peak, and decay in indo-1 intensity. To confirm that Ca2+ entry participates in Ca2+ spikes, cells were treated with BAPTA-AM or EDTA, which are intracellular and extracellular Ca2+ chelators, respectively. Fig. 2 ⇓ , trace 2 shows an experiment identical to that of trace 1, except that BAPTA-AM was injected into the sample holder to give a final concentration of 50 μm. Within 3 min, the Ca2+ spike amplitude began to decrease, similar to that we have described previously in leukocytes (29) . Similarly, rapid removal of extracellular Ca2+ by the addition of 5 mm EDTA in Ca2+-free HBSS, to remove Ca2+ in the buffer, also blocked Ca2+ spikes (trace 3). Hence, extracellular Ca2+ participates in the formation of intracellular Ca2+ spikes. No changes in Ca2+ spike frequency or amplitude were observed when cells were treated with 15 μm SKF96365, 1 μm diltiazem, 4 μm verapamil, and 1 μm nicardipine (Fig. 2 ⇓ , traces 4–7, respectively). These concentrations were chosen as they correspond to the levels associated with specific Ca2+ channel blockage; e.g., nicardipine is a HVA (L-type) Ca2+ channel blocker effective in vitro at this concentration (38) . The NVG channel blocker and antimetastatic agent CAI, used at 10 μm for these in vitro studies (39) , reduced Ca2+ spikes to Ca2+ “bumps,” which was then followed by elimination of the Ca2+ signal (Fig. 2 ⇓ , trace 8). In the experiment of Fig. 2 ⇓ , trace 9, 1.5 μm mibefradil, a T-type channel blocker, was added at the time indicated by the arrow. Within ∼3–4 min, the Ca2+ spikes were replaced by very low-intensity bumps, which then disappeared. Similar results were obtained using Gd3+, a specific TRP (40) , and stretch-activated cation channel blocker (41) . Again, Ca2+ spikes diminished and then disappeared (Fig. 2 ⇓ , trace 10). The Ca2+ bumps were then evaluated using the short-time base settings (Fig. 3 ⇓ , trace 2). These experiments revealed that Ca2+ bumps closely resemble the intensity shoulder noted previously for untreated HT1080 cells (Fig. 3 ⇓ , trace 1).

Fig. 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2.

Effect of SKF96365, diltiazem, verapamil, nicardipine, carboxyamido-triazole (CAI), mibefradil, and Gd3+ on Ca2+ spikes in HT1080 cells. Indo-1-labeled HT1080 cells were allowed to polarize on coverslips. Ca2+ spikes were followed over time using a microfluorometry apparatus. Experiments were performed using long-time base to reveal changes in Ca2+ spikes over a period of minutes after the addition of reagents (arrows). The addition of PBS (trace 1), BAPTA (50 μm; trace 2), EDTA (5 mm; trace 3), SKF96365 (15 μm; trace 4), diltiazem (1 μm; trace 5), verapamil (4 μm; trace 6), and nicardipine (1 μm; trace 7) had no effect on Ca2+ spikes of HT1080 cells. However, when CAI (10 μm; trace 8), mibefradil (1.5 μm; trace 9), or Gd3+ (1.5 μm; trace 10) were added to cells, the fluorescence intensity of spikes diminished greatly, thus forming small Ca2+ “bumps.” The Ca2+ signals were eliminated within minutes. Bar = 2000 counts (n = 3).

Fig. 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 3.

Evaluation of Ca2+ spikes using a short-time base for data acquisition. Experiments were performed as described in the previous figure, except that a short-time base was used to provide the fine structure of the Ca2+ spikes. A typical Ca2+ spike profile of an untreated HT1080 cell consists of a low-intensity shoulder on the leading edge and brief peak, followed by a decay in indo-1 intensity (trace 1). However, when cells were treated with Gd3+ (1.5 μm), the Ca2+ spike was replaced within minutes by a very low-intensity bump, which resembles the shoulder of a typical spike. Parallel results were obtained with the various inhibitors described in Fig. 2 ⇓ (data not shown; n = 3).

The HT1080 Ca2+ Spike Is a Perimembrane Ca2+ Wave whose Propagation Is Affected by Mibefradil and Gd3+.

Recent studies from this laboratory have shown that Ca2+ spikes of polarized neutrophils and transfectants are associated with certain intracellular Ca2+ waves (29 , 34) . To visualize these waves, images must be collected using very short shutter speeds to avoid image blurring attributable to wave motion and indo-1 diffusion while the shutter is open. A high-speed imaging method was developed to detect these waves (29 , 34, 35, 36, 37) . High-speed microscopy shows that the Ca2+ spike (Fig. 2 ⇓ , trace 1; Fig. 3 ⇓ , trace 1) is a counterclockwise (in the microscope’s frame of reference) Ca2+ wave (Fig. 4A) ⇓ , e.g., in Fig. 4A ⇓ , frames 2–16, the bright spot is a region of high Ca2+ concentration brought about by the local opening of Ca2+ channels. Because indo-1 has a relatively high affinity for Ca2+ and a finite amount of time is required for the signaling apparatus to pump down free cytosolic Ca2+, a low-intensity “tail” is observed next to the region of bright Ca2+-indo-1 fluorescence (i.e., the Ca2+ wave has a low-intensity tail on the side opposite to the direction of wave motion). This wave was found to travel with a velocity of ∼200 μm/s. However, after the addition of mibefradil, a brief Ca2+ spark was observed at the lamellipodium, although no propagating Ca2+ wave was found (Fig. 4B) ⇓ . Similarly, a Ca2+ wave was observed in cells before (Fig. 4C) ⇓ but not after (Fig. 4D) ⇓ the addition of Gd3+. Thus, the regular Ca2+ spikes observed in migrating tumor cells are counterclockwise waves, when viewed from the bottom of the cell on a coverslip. Furthermore, the shoulder of the temporal Ca2+ spike likely corresponds to the temporal bump and spatiotemporal spark noted above. These waves are blocked by mibefradil and Gd3+, which suggests that their binding sites, including LVG and NVG channels, participate in wave propagation around the cell or ignition of the wave at the level of the plasma membrane.

Fig. 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 4.

High-speed imaging reveals Ca2+ waves in HT1080 cells. Micrographs of indo-1-labeled cells were acquired using a 100-ns shutter speed and 30-μs duty cycle. The Ca2+ spikes of Figs. 2 ⇓ and 3 ⇓ were found to be Ca2+ waves propagating in the perimembrane region of polarized HT1080 cells when viewed using high-speed microscopy. In A, frame 1 shows a differential interference contrast microscopy micrograph of an HT1080 cell. In A, frames 2–16 show a corresponding series of high-speed fluorescence micrographs of this cell. A Ca2+ wave begins at the leading edge of the cell and then propagates in a counterclockwise direction (A, frames 2–16). However, when this same cell was treated with mibefradil (1.5 μm; B), Ca2+ wave propagation was blocked. A brief Ca2+ spark was observed in mibefradil-treated cells (arrow in B, frames 4 and 5). C and D, another cell before (C) and after (D) treatment with Gd3+. A perimembrane Ca2+ wave was observed in the cell before treatment, whereas a dim Ca2+ spark was observed after exposure to Gd3+ (1.5 μm; D, arrows). Consecutive signals are shown in A and B and C and D. In B and D, the Ca2+ sparks soon disappeared (n = 4; ×840).

Mibefradil and Gd3+ Inhibit HT1080 Migration.

The central role of Ca2+ and Ca2+ oscillations in cell motility and ability of mibefradil and Gd3+ to influence these oscillations and waves suggest that these reagents may affect tumor cell motility. The phagokinetic track assay was used to test the ability of mibefradil and Gd3+ to inhibit HT1080 cell motility (32 , 33) . HT1080 cells were incubated on gold particle-coated glass coverslips for 22 h. As cells migrate on these surfaces, the gold particles are cleared from regions of the surface and frequently picked up by the cells. This makes the cells appear darker and surrounding area appear lighter when viewed by microscopy. Fig. 5 ⇓ shows representative micrographs of this assay. In the absence of added reagents, large areas of the surface are cleared by the cells, as the cells become darker (Fig. 5A) ⇓ . As shown by brightfield microscopy, we observed that the intra and extracellular Ca2+ chelators BAPTA (25 μm) and EDTA (5 mm) blocked cell motility. The Ca2+ channel blockers, 10 μm CAI (Fig. 5D) ⇓ , 1.5 μm mibefradil (Fig. 5E) ⇓ , and 1.5 μm Gd3+ (Fig. 5F) ⇓ , significantly decreased the ability of HT1080 cells to clear the surrounding surface. However, at concentrations of SKF96365, diltiazem, verapamil, and nicardipine expected to block the relevant Ca2+ channels, no inhibitory effect could be observed (Fig. 5, G–J) ⇓ . Quantitative data were also acquired by analyses of these micrographs. Because the size of HT1080 cells varies considerably, a swept area ratio, which equals to total swept area divided by cell area, was used to evaluate cell motility. These data reiterated the fact that mibefradil and Gd3+ significantly inhibited cell motility in a dose-dependent manner (Fig. 6) ⇓ . Six μm Gd3+ almost completely abolished HT1080 movement (Fig. 6B) ⇓ , and 5 μm mibefradil decreased the cell-swept area ∼90% compared with controls (Fig. 6A) ⇓ . Thus, both qualitative and quantitative data indicate that blockade of LVG and NVG channels, but not L-type Ca2+ channels, diminishes HT1080 cell motility.

Fig. 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 5.

Effect of Ca2+ channel blockers on HT1080 motility. A suspension of HT1080 cells with or without calcium channel blockers was seeded onto gold-coated coverslips. Brightfield microscopy was performed after incubation at 37°C. The extent of cell motility is indicated by the amount of neighboring area cleared by the cells. An untreated cell is shown in A. Control experiments using treatment with the intra and extracellular Ca2+ chelators BAPTA (25 μm; B) and EDTA (5 mm; C) showed an absence of cell motility. Treatment with carboxyamido-triazole (CAI; 10 μm; D), mibefradil (1.5 μm; E), or Gd3+ (1.5 μm; F) significantly reduced HT1080 area cleared by the cells. However, SKF96365 (15 μm; G), diltiazem (1 μm; H), verapamil (4 μm; I), and nicardipine (1 μm; J) had no effect on cell migration (n = 3; ×80).

Fig. 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 6.

Dose-dependent inhibition of HT1080 cell motility by mibefradil and Gd3+. HT1080 cells treated with various doses of mibefradil (A) or Gd3+ (B) were incubated on gold-coated coverslips. The area cleared by each cell was measured using Scion Image software. The swept area ratio was obtained by dividing the total swept area by the cell area. Both mibefradil and Gd3+ effectively inhibited HT1080 cell motility in a dose-dependent manner (n = 4; ∗, P < 0.001).

Previous studies have shown that fibronectin mobilizes Ca2+ from internal and external stores to the tumor cell cytoplasm (42) . We confirmed this fact for HT1080 cells. Coverslips were coated with fibronectin as described (43) , and then indo-1-labeled HT1080 cells were allowed to attach to the surface. Ca2+ spikes were observed at a much higher frequency, thus indicating an enhancement of the Ca2+-signaling apparatus (data not shown). No significant change in cell migration was observed in the presence of 25 μg/ml fibronectin for untreated, control, or drug-treated samples (data not shown). Although fibronectin influences the Ca2+ signals, it does not affect the ability of channel blockers to influence cell motility.

Mibefradil and Gd3+ Inhibit HT1080 Cell Invasiveness.

Because cell motility is required for invasion, we tested the ability of mibefradil and Gd3+ to inhibit HT1080 cell invasion. Biocoat Matrigel invasion chambers were used for HT1080 cell invasion experiments. Cell suspensions were loaded to the top chamber with or without the addition of mibefradil, Gd3+, nicardipine, or other reagents. After a 22-h incubation period, transmigrated cells on the underside of the inserts were fixed, stained, and counted. Both mibefradil and Gd3+ inhibited HT1080 cell transmigration in a dose-dependent fashion (Fig. 7) ⇓ . However, nicardipine, SKF96365, verapamil, and diltiazem had no effect on cell invasiveness at pharmacologically appropriate doses (Fig. 8) ⇓ . Moreover, when the lowest doses of mibefradil and Gd3+ that exhibit maximal inhibition of invasiveness (5 and 6 μm, respectively; Fig. 7 ⇓ ) were used simultaneously, the drug combination further augmented inhibition (Fig. 8) ⇓ . Inhibition (95%) was seen using the combination of 5 μm mibefradil and 20 μm Gd3+. The complementary action of these two reagents is consistent with their ability to act on two different membrane sites contributing to the same physical wave. Similarly, CAI plus mibefradil showed a significant reduction in invasiveness in comparison with mibefradil alone. Therefore, HT1080 cell invasion was regulated by T-type and NVG Ca2+ channels but not L-type Ca2+ channels.

Fig. 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 7.

Dose-dependent inhibition of HT1080 invasion of Matrigel by mibefradil and Gd3+. HT1080 cell suspensions (105/ml) were loaded onto the top Matrigel chamber with or without the addition of various concentrations of mibefradil or Gd3+. A final concentration of 25 μg/ml fibronectin was added to the bottom chamber medium as a chemoattractant. After a 22-h incubation, transmigrated cells on the bottom side of the inserts were fixed, stained, and counted. Both mibefradil (A) and Gd3+ (B) inhibited HT1080 cell invasion in a dose-dependent fashion (n = 4; ∗, P < 0.001).

Fig. 8.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 8.

The combined inhibitory effect of T-type and nonvoltage-gated channel blockers on HT1080 invasion. Matrigel chambers were used as described in Fig. 7 ⇓ . Untreated and negative control Ca2+ channel blockers [SKF96365 (15 μm), diltiazem (1 μm), verapamil (4 μm), and nicardipine (1 μm)] gave similar levels of cell invasiveness. Carboxyamido-triazole (CAI; 5 μm), mibefradil (5 μm), and Gd3+ (6 μm) showed significant inhibition of cell invasion. When 5 μm mibefradil and 6 μm Gd3+ were added simultaneously to cells, the inhibition was enhanced ≤95%. The combination of CAI (20 μm) and mibefradil (5 μm) also showed greater inhibition of cell invasiveness (n = 4; ∗, P < 0.001 in comparison with controls; ∗∗, P < 0.01 with respect to the comparisons indicated).

DISCUSSION

Previous in vitro and in vivo studies have suggested that Ca2+ channels are important in tumor cell proliferation and invasion (23 , 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55) . Indeed, clinical trials of Ca2+-active reagents have already been reported (50 , 56, 57, 58) , e.g., verapamil, a HVA Ca2+ channel blocker, has been used in vitro and in combined therapy approaches (48, 49, 50, 51, 52) . At higher doses, verapamil also blocks potassium channels (59) , which may lead to some ambiguity in its mechanism of action. CAI is a promising anticancer agent acting on NVG channels, which is in Phase I and II clinical trials (56, 57, 58) . The present study uses microfluorometry and high-speed imaging to characterize Ca2+ signals in HT1080 cells. Although a recent study has suggested that Ca2+ waves are present in tumor cells (10) , we now rigorously demonstrate this fact. Furthermore, inhibitors of this Ca2+ wave, which were identified as NVG and LVA channel blockers, reduce dramatically cell motility and invasiveness. Our studies provide new insights into tumor cell migration and unprecedented detail concerning the cellular effects of Ca2+-active reagents on tumor cells.

As we have emphasized (29 , 35 , 60) , intracellular Ca2+ waves, which are the Ca2+ signal, can be very heterogeneous in their physical properties (e.g., ignition, shape, location, direction, velocity, number, etc.); thus, a Ca2+ signal is not an amount but rather a great variety of time-varying chemical patterns (60) . The Ca2+ wave associated with HT1080 cells travels about the periphery of the cytoplasm. These results are similar to our recent analysis of Ca2+ spikes and counterclockwise Ca2+ waves of morphologically polarized neutrophils (29) . Ca2+ signals of both neutrophils and HT1080 tumor cells were not sensitive to HVA type Ca2+ channel blockers (29) . Although HVA channels have been reported to regulate insect hemocyte adhesion (61) and mammalian neuronal migration (62) , we demonstrated that they had no effect on HT1080 cell motility (Fig. 5) ⇓ and invasion (Fig. 7) ⇓ . We demonstrated that the counterclockwise Ca2+ wave could be blocked by mibefradil and Gd3+, suggesting the association of LVA and TRP channels with Ca2+ signaling in HT1080 cells. Furthermore, these two reagents apparently act early in wave propagation as a temporal “bump,” or a spatio-temporal spark of Ca2+ is observed. Thus, the timing mechanism regulating cell motility seems to be intact (as suggested by the occurrence of these bumps), at least for a few minutes, although wave propagation and motility are not. This change in Ca2+ signaling is likely to be the underlying biophysical mechanism accounting for the cellular effects of mibefradil and Gd3+. As these reagents act on different proteins participating in the formation of the same chemical wave, we tested their ability to complementarily inhibit cell function. Although neither of these reagents completely blocked cell movement and invasion, the combination of mibefradil and Gd3+ inhibited ∼95% of HT1080 cell invasion.

The studies reported above provide some insight into the nature of Ca2+ signaling associated with cell motility. On the basis of these and earlier (29 , 35) studies, we suggest that the initial Ca2+ “flash” or “bump” is associated with the endoplasmic reticulum or a component of the endoplasmic reticulum closely associated with the plasma membrane. Alternatively, the TRP channel could be responding to cytoskeletal interactions or changes in membrane stress (63 , 64) . In either case, we speculate that TRP or TRP-like channels communicate this signal in a Gd3+-sensitive fashion to the plasma membrane. T-type Ca2+ channels propagate this Ca2+ signal at the plasma membrane, as suggested by mibefradil inhibition. T-type channels (LVA) are activated by small depolarizations of the plasma membrane, which promote a Ca2+-permeable state and its accompanying depolarization. This depolarization allows the signal to propagate about the cell periphery. This Ca2+ signal may participate in regulating cell migration through its effects on integrins, the cytoskeleton, membrane recycling, and other cellular processes.

Our in vitro studies of tumor cell Ca2+ signaling and behavior lead to several points of potential clinical relevance: (a) CAI, a subject of clinical trials (56, 57, 58) , is likely acting on the same Ca2+ pathway and cell functions described in this study; (b) because mibefradil is also acting on this same physical Ca2+ signal, and augments the inhibition of cell motility and invasiveness in vitro, it may be possible to improve clinical outcomes with CAI by combining treatment protocols with mibefradil. However, mibefradil was removed from the market because of dangerous drug interactions. Mibefradil analogues, which do not exhibit such drug interactions, is a viable alternative; (c) because this dynamic microscopic technique could be used with tissue samples or isolated leukocytes from patients (which display a similar pattern of NVG and LVG channels), it might be possible to adjust doses for each patient. This controls for potential genetic variations in the Ca2+ signaling apparatus among patients. Moreover, the temporal features of tumor cell signaling may be central in patient evaluation and devising new treatment strategies; and (d) because the concentration of Gd3+ used in the present in vitro studies is lower than the doses leading to illness in experimental animals (65) , it might provide another therapeutic route. Thus, high-speed imaging is useful in evaluating the underlying dynamic biophysical properties of tumor cells and may significantly contribute to translational medicine.

Acknowledgments

We thank Dr. R. Schultz, Drug Synthesis & Chemistry Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute (Bethesda, MD), for making available a sample of CAI.

Footnotes

  • Grant support: NIH Grant CA74120 (H. R. Petty).

  • The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • Requests for reprints: Dr. Howard R. Petty, Department of Ophthalmology and Visual Sciences, The University of Michigan Medical School, 1000 Wall Street, Ann Arbor, MI 48105. Phone: (734) 647-0384; Fax: (734) 936-3815; E-mail: hpetty{at}umich.edu

  • Received November 7, 2003.
  • Revision received December 23, 2003.
  • Accepted January 26, 2004.
  • ©2004 American Association for Cancer Research.

References

  1. ↵
    Mareel M, Leroy A. Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev, 83: 337-76, 2003.
    OpenUrlCrossRefPubMed
  2. ↵
    Entschladen F, Zanker KS. Locomotion of tumor cells: a molecular comparison to migrating pre- and postmitotic leukocytes. J Cancer Res Clin Oncol, 126: 671-81, 2000.
    OpenUrlCrossRefPubMed
  3. ↵
    Komuro H, Rakic P. Intracellular Ca2+ fluctuations modulate the rate of neuronal migration. Neuron, 17: 275-85, 1996.
    OpenUrlCrossRefPubMed
  4. ↵
    Mandeville JT, Ghosh RN, Maxfield FR. Intracellular calcium levels correlate with speed and persistent forward motion in migrating neutrophils. Biophys J, 68: 1207-17, 1995.
    OpenUrlCrossRefPubMed
  5. ↵
    Hahn K, DeBiasio R, Taylor DL. Patterns of elevated free calcium and calmodulin activation in living cells. Nature, 359: 736-8, 1992.
    OpenUrlCrossRefPubMed
  6. ↵
    Brundage RA, Fogarty KE, Tuft RA, Fay FS. Calcium gradients underlying polarization and chemotaxis of eosinophils. Science, 254: 703-6, 1991.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Giannone G, Ronde P, Gaire M, Haiech J, Takeda K. Calcium oscillations trigger focal adhesion disassembly in human U87 astrocytoma cells. J Biol Chem, 277: 26364-71, 2002.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Lang K, Niggemann B, Zanker KS, Entschladen F. Signal processing in migrating T24 human bladder carcinoma cells: role of the autocrine interleukin-8 loop. Int J Cancer, 99: 673-80, 2002.
    OpenUrlCrossRefPubMed
  9. ↵
    Dittmar T, Husemann A, Schewe Y, Nofer JR, Niggemann B, Zanker KS, Brandt BH. Induction of cancer cell migration by epidermal growth factor is initiated by specific phosphorylation of tyrosine 1248 of c-erbB-2 receptor via EGFR. FASEB J, 16: 1823-5,
  10. ↵
    Ronde P, Giannone G, Gerasymova I, Stoeckel H, Takeda K, Haiech J. Mechanism of calcium oscillations in migrating human astrocytoma cells. Biochim Biophys Acta, 1498: 273-80, 2000.
    OpenUrlPubMed
  11. ↵
    Hofmann F, Lacinova L, Klugbauer N. Voltage-dependent calcium channels: from structure to function. Rev Physiol Biochem Pharmacol, 139: 33-87, 1999.
    OpenUrlCrossRefPubMed
  12. ↵
    N’Gouemo P, Morad M. Voltage-gated calcium channels in adult rat inferior colliculus neurons. Neuroscience, 120: 815-26, 2003.
    OpenUrlCrossRefPubMed
  13. ↵
    Benitah JP, Gomez AM, Fauconnier J, et al Voltage-gated Ca2+ currents in the human pathophysiologic heart: a review. Basic Res Cardiol, 97(Suppl 1): I11-8, 2002.
    OpenUrl
  14. ↵
    Perez-Reyes E. Molecular physiology of low-voltage-activated T-type calcium channels. Physiol Rev, 83: 117-61, 2003.
    OpenUrlCrossRefPubMed
  15. ↵
    McDonald TF, Pelzer S, Trautwein W, Pelzer DJ. Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells. Physiol Rev, 74: 365-507, 1994.
    OpenUrlCrossRefPubMed
  16. ↵
    Hille B eds. . Ionic channels of excitable membranes, Sinauer Sunderland, MA 2001.
  17. ↵
    Vennekens R, Voets T, Bindels RJ, Droogmans G, Nilius B. Current understanding of mammalian TRP homologues. Cell Calcium, 31: 253-64, 2002.
    OpenUrlCrossRefPubMed
  18. ↵
    Montell C. New light on TRP and TRPL. Mol Pharmacol, 52: 755-63, 1997.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Clapham DE, Runnels LW, Strubing C. The TRP ion channel family. Nat Rev Neurosci, 2: 387-96, 2001.
    OpenUrlCrossRefPubMed
  20. ↵
    Welsh DG, Morielli AD, Nelson MT, Brayden JE. Transient receptor potential channels regulate myogenic tone of resistance arteries. Circ Res, 90: 248-50, 2002.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    Jung S, Strotmann R, Schultz G, Plant TD. TRPC6 is a candidate channel involved in receptor-stimulated cation currents in A7r5 smooth muscle cells. Am J Physiol, 282: C347-59, 2002.
    OpenUrlCrossRef
  22. ↵
    Ge S, Rempel SA, Divine G, Mikkelsen T. Carboxyamido-triazole induces apoptosis in bovine aortic endothelial and human glioma cells. Clin Cancer Res, 6: 1248-54, 2000.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    Wu Y, Palad AJ, Wasilenko WJ, et al Inhibition of head and neck squamous cell carcinoma growth and invasion by the calcium influx inhibitor carboxyamido-triazole. Clin Cancer Res, 3: 1915-21, 1997.
    OpenUrlAbstract
  24. ↵
    Bauer KS, Cude KJ, Dixon SC, Kruger EA, Figg WD. Carboxyamido-triazole inhibits angiogenesis by blocking the calcium-mediated nitric-oxide synthase-vascular endothelial growth factor pathway. J Pharmacol Exp Ther, 292: 31-7, 2000.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    Blaheta RA, Hailer NP, Brude N, et al Novel mode of action of the calcium antagonist mibefradil (Ro 40–5967): potent immunosuppression by inhibition of T-cell infiltration through allogeneic endothelium. Immunology, 94: 213-20, 1998.
    OpenUrlCrossRefPubMed
  26. ↵
    Nebe B, Holzhausen C, Rychly J, Urbaszek W. Impaired mechanisms of leukocyte adhesion in vitro by the calcium channel antagonist mibefradil. Cardiovasc Drugs Ther, 16: 183-93, 2002.
    OpenUrlCrossRefPubMed
  27. ↵
    Hardie RC. Whole-cell recordings of the light induced current in dissociated Drosophila photoreceptors: evidence for feedback by calcium permeating the light-sensitive channels. Proc R Soc Lond B Biol Sci, 245: 203-10, 1991.
    OpenUrlCrossRef
  28. ↵
    Scott K, Sun Y, Beckingham K, Zuker CS. Calmodulin regulation of Drosophila light-activated channels and receptor function mediated termination of the light response in vivo. Cell, 91: 375-83, 1997.
    OpenUrlCrossRefPubMed
  29. ↵
    Kindzelskii AL, Petty HR. Intracellular calcium waves accompany neutrophil polarization, formylmethionylleucylphenylalanine stimulation, and phagocytosis: a high speed microscopy study. J Immunol, 170: 64-72, 2003.
    OpenUrlAbstract/FREE Full Text
  30. ↵
    Andreasen D, Jensen BL, Hansen PB, Kwon TH, Nielsen S, Skott O. The α(1G)-subunit of a voltage-dependent Ca(2+) channel is localized in rat distal nephron and collecting duct. Am J Physiol Renal Physiol, 279: F997-1005, 2000.
    OpenUrlPubMed
  31. ↵
    Weiergraber M, Pereverzev A, Vajna R, et al Immunodetection of α1E voltage-gated Ca(2+) channel in chromogranin-positive muscle cells of rat heart, and in distal tubules of human kidney. J Histochem Cytochem, 48: 807-19, 2000.
    OpenUrlCrossRefPubMed
  32. ↵
    Albrecht-Buehler G. The phogokinetic tracks of 3T3 cells. Cell, 11: 395-404, 1977.
    OpenUrlCrossRefPubMed
  33. ↵
    Scott WN, McCool K, Nelson J. Improved method for the production of gold colloid monolayers for use in the phagokinetic track assay for cell motility. Anal Biochem, 287: 343-4, 2000.
    OpenUrlCrossRefPubMed
  34. ↵
    Wang JH, Manning BJ, Wu QD, Blankson S, Bouchier-Hayes D, Redmond HP. Endotoxin/lipopolysaccharide activates NF-κ B and enhances tumor cell adhesion and invasion through a β 1 integrin-dependent mechanism. J Immunol, 170: 795-804, 2003.
    OpenUrlAbstract/FREE Full Text
  35. ↵
    Worth RG, Kim M-K, Kindzelskii AL, Petty HR, Schreiber AD. Signal sequence within FcγRIIA controls calcium wave propagation patterns: apparent role in phagolysosome fusion. Proc Natl Acad Sci USA, 100: 4533-8, 2003.
    OpenUrlAbstract/FREE Full Text
  36. ↵
    Kindzelskii AL, Petty HR. Apparent role of traveling metabolic waves in periodic oxidant release by living cells. Proc Natl Acad Sci USA, 99: 9207-12, 2002.
    OpenUrlAbstract/FREE Full Text
  37. ↵
    Petty HR, Worth RG, Kindzelskii AL. Imaging sustained dissipative patterns in the metabolism of individual living cells. Phys Rev Lett, 84: 2754-7, 2000.
    OpenUrlCrossRefPubMed
  38. ↵
    Hagiwara K, Nakagawasai O, Murata A, et al Analgesic action of loperamide, an opioid agonist, and its blocking action on voltage-dependent Ca2+ channels. Neurosci Res, 46: 493-7, 2003.
    OpenUrlCrossRefPubMed
  39. ↵
    Rust WL, Huff JL, Plopper GE. Screening assay for promigratory/antimigratory compounds. Anal Biochem, 280: 11-19, 2000.
    OpenUrlCrossRefPubMed
  40. ↵
    Trebak M, Bird GS, McKay RR, Putney JW, Jr Comparison of human TRPC3 channels in receptor-activated and store-operated modes. Differential sensitivity to channel blockers suggests fundamental differences in channel composition. J Biol Chem, 277: 21617-23, 2002.
    OpenUrlAbstract/FREE Full Text
  41. ↵
    Yang XC, Sachs F. Block of stretch-activated ion channels in Xenopus oocytes by gadolinium and calcium ions. Science, 243: 1068-71, 1989.
    OpenUrlAbstract/FREE Full Text
  42. ↵
    Shahan TA, Fawzi A, Bellon G, Monboisse JC, Kefalides NA. Regulation of tumor cell chemotaxis by type IV collagen is mediated by a Ca2+-dependent mechanism requiring CD47 and the integrin αVβ3. J Biol Chem, 275: 4796-802, 2000.
    OpenUrlAbstract/FREE Full Text
  43. ↵
    Xue W, Mizukami I, Todd RF, III, Petty HR. Urokinase-type plasminogen activator receptors associate with β1 and β3 integrins of fibrosarcoma cells: dependence on extracellular matrix components. Cancer Res, 57: 1682-9, 1997.
    OpenUrlAbstract/FREE Full Text
  44. ↵
    Alessandro R, Masiero L, Liotta LA, Kohn EC. The role of calcium in the regulation of invasion and angiogenesis. In Vivo, 10: 153-60, 1996.
    OpenUrlPubMed
  45. ↵
    Vilpo J, Koski T, Vilpo L. Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro. Haematologica, 85: 806-13, 2000.
    OpenUrlAbstract/FREE Full Text
  46. ↵
    Gaffen JD, Stamford IF, Chambers E, Tavares IA, Bennett A. The effect of nifedipine alone or combined with cytotoxic chemotherapy on the mouse NC carcinoma in-vitro and in-vivo. J Pharm Pharmacol, 43: 401-5, 1991.
    OpenUrlPubMed
  47. ↵
    Fink-Puches R, Helige C, Kerl H, Smolle J, Tritthart HA. Inhibition of melanoma cell directional migration in vitro via different cellular targets. Exp Dermatol, 2: 17-24, 1993.
    OpenUrlCrossRefPubMed
  48. ↵
    Rybalchenko V, Prevarskaya N, Van Coppenolle F, et al Verapamil inhibits proliferation of LNCaP human prostate cancer cells influencing K+ channel gating. Mol Pharmacol, 59: 1376-87, 2001.
    OpenUrlAbstract/FREE Full Text
  49. ↵
    Yohen KH, Clothier JL, Montague SL, et al Inhibition of tumor cell invasion by verapamil. Pigment Cell Res, 4: 225-33, 1991.
    OpenUrlCrossRefPubMed
  50. ↵
    Taylor CW, Dalton WS, Mosley K, Dorr RT, Salmon SE. Combination chemotherapy with cyclophosphamide, vincristine, adriamycin, and dexamethasone (CVAD) plus oral quinine and verapamil in patients with advanced breast cancer. Breast Cancer Res Treatment, 42: 7-14, 1997.
    OpenUrlCrossRefPubMed
  51. ↵
    Farias EF, Aguirre Ghiso JA, Ladeda V, Bal DeKier Joffe E. Verapamil inhibits tumor protease production, local invasion and metastasis development in murine carcinoma cells. Int J Cancer, 78: 727-34, 1998.
    OpenUrlCrossRefPubMed
  52. ↵
    Iishi H, Tatsuta M, Baba M, Yano H, Sakai N, Uehara H, Nakaizumi A. Suppression by verapamil of bombesin-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats. Chemotherapy, 47: 70-6, 2001.
    OpenUrlCrossRefPubMed
  53. ↵
    Zeitler H, Ko Y, Glodny B, et al Cell-cycle arrest in G0/G1 phase of growth factor-induced endothelial cell proliferation by various calcium channel blockers. Cancer Detect Prev, 21: 332-9, 1997.
    OpenUrlPubMed
  54. ↵
    Kohn EC, Felder CC, Jacobs W, et al Structure-function analysis of signal and growth inhibition by carboxyamido-triazole, CAI. Cancer Res, 15: 935-42, 1994.
    OpenUrl
  55. ↵
    Lambert PA, Somers KD, Kohn EC, Perry RR. Antiproliferative and antiinvasive effects of carboxyamido-triazole on breast cancer cell lines. Surgery, 122: 372-9, 1997.
    OpenUrlCrossRefPubMed
  56. ↵
    Berlin J, Tutsch KD, Arzoomanian RZ, et al Phase I and pharmacokinetic study of a micronized formulation of carboxyamidotriazole, a calcium signal transduction inhibitor: toxicity, bioavailability and the effect of food. Clin Cancer Res, 8: 86-94, 2002.
    OpenUrlAbstract/FREE Full Text
  57. ↵
    Kohn EC, Reed E, Sarosy GA, et al A phase I trial of carboxyamido-triazole and paclitaxel for relapsed solid tumors: potential efficacy of the combination and demonstration of pharmacokinetic interaction. Clin Cancer Res, 7: 1600-9, 2001.
    OpenUrlAbstract/FREE Full Text
  58. ↵
    Bauer KS, Figg WD, Hamilton JM, et al A pharmacokinetically guided Phase II study of carboxyamido-triazole in androgen-independent prostate cancer. Clin Cancer Res, 5: 2324-9, 1999.
    OpenUrlAbstract/FREE Full Text
  59. ↵
    Robe RJ, Grissmer S. Block of the lymphocyte K+ channel mKv1.3 by the phenylalkylamine verpamil: kinetic aspect of block and disruption of accumulation of block by a single point mutation. Br J Pharmacol, 13: 1275-84, 2000.
    OpenUrl
  60. ↵
    Petty HR. Biomedical applications of high-speed microscopy. Optics & Photonics News, 15: 35-40, 2004.
    OpenUrl
  61. ↵
    Ottaviani E, Sassi D, Kletsas D. PDGF- and TGF-B-induced changes in cell shape of invertebrate immunocytes: effect of calcium entry blockers. Eur J Cell Biol, 74: 336-41, 1997.
    OpenUrlPubMed
  62. ↵
    Komuro H, Rakic P. Selective role of N-type calcium channels in neuronal migration. Science, 257: 806-9, 1992.
    OpenUrlAbstract/FREE Full Text
  63. ↵
    Lee J, Ishihara A, Oxford G, Johnson B, Jacobson K. Regulation of cell movement is mediated by stretch-activated calcium channels. Nature, 400: 382-6, 1999.
    OpenUrlCrossRefPubMed
  64. ↵
    Glogauer M, Ferrier J, McCulloch CAG. Magnetic fields applied to collagen-coated ferric oxide beads induce stretch-activated Ca2+ flux in human fibroblasts. Am J Physiol, 269: C1093-1104, 1995.
    OpenUrlPubMed
  65. ↵
    Pereira DT, Nozaki PN, Menani JV, Colombari E, De Luca LA, Schoorlemmer GH. Effect of the gadolinium ion on body fluid regulation. Pharmacol Biochem Behav, 76: 275-83, 2003.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
Cancer Research: 64 (7)
April 2004
Volume 64, Issue 7
  • Table of Contents
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Identification of Channels Promoting Calcium Spikes and Waves in HT1080 Tumor Cells
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Identification of Channels Promoting Calcium Spikes and Waves in HT1080 Tumor Cells
Ji-Biao Huang, Andrei L. Kindzelskii, Andrea J. Clark and Howard R. Petty
Cancer Res April 1 2004 (64) (7) 2482-2489; DOI: 10.1158/0008-5472.CAN-03-3501

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Identification of Channels Promoting Calcium Spikes and Waves in HT1080 Tumor Cells
Ji-Biao Huang, Andrei L. Kindzelskii, Andrea J. Clark and Howard R. Petty
Cancer Res April 1 2004 (64) (7) 2482-2489; DOI: 10.1158/0008-5472.CAN-03-3501
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Inhibition of DNA Methylation Sensitizes Glioblastoma for Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Mediated Destruction
  • Context-Dependent Hormone-Refractory Progression Revealed through Characterization of a Novel Murine Prostate Cancer Cell Line
  • High Expression of ErbB Family Members and Their Ligands in Lung Adenocarcinomas That Are Sensitive to Inhibition of Epidermal Growth Factor Receptor
Show more Cell and Tumor Biology
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement